Cargando…

Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials

BACKGROUND: Cerebral microvascular dysfunction is commonly seen in Alzheimer’s disease (AD) and vascular cognitive impairment (VCI). Cerebrovascular reactivity (CVR) to CO(2) reflects cerebral microvascular health and may be modulated by the renin–angiotensin system (RAS). This study aimed to invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henley, Brandon, Okafor, Maureen, Kulshreshtha, Ambar, Trammell, Antoine, Hajjar, Ihab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311938/ https://www.ncbi.nlm.nih.gov/pubmed/36645213 http://dx.doi.org/10.1177/17474930231153313

Ejemplares similares

Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial
por: Hajjar, Ihab, et al.
Publicado: (2020)

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease
por: Hajjar, Ihab, et al.
Publicado: (2022)

Associations of Atrial Fibrillation with Mild Cognitive Impairment and Dementia: An Investigation Using SPRINT Research Materials
por: Alam, Aniqa B., et al.
Publicado: (2022)

Association of Stress With Cognitive Function Among Older Black and White US Adults
por: Kulshreshtha, Ambar, et al.
Publicado: (2023)

Interactions of Insula Subdivisions-Based Networks with Default-Mode and Central-Executive Networks in Mild Cognitive Impairment
por: Chand, Ganesh B., et al.
Publicado: (2017)

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)
por: Bönner, Gerd, et al.
Publicado: (2011)

Candesartan prevents impairment of recall caused by repeated stress in rats
por: Braszko, Jan Józef, et al.
Publicado: (2012)

Candesartan in heart failure
por: Ripley, Toni L, et al.
Publicado: (2006)

Dataset on significant role of Candesartan on cognitive functions in rats having memory impairment induced by electromagnetic waves
por: Nasser, Mohamad, et al.
Publicado: (2018)

Development of digital voice biomarkers and associations with cognition, cerebrospinal biomarkers, and neural representation in early Alzheimer's disease
por: Hajjar, Ihab, et al.
Publicado: (2023)

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients
por: Baroroh, Faridah, et al.
Publicado: (2019)

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease
por: Liu-Seifert, Hong, et al.
Publicado: (2015)

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
por: van Bergen, J. M. G., et al.
Publicado: (2016)

Cerebral Microbleeds Are Associated With Mild Cognitive Impairment in Patients With Hypertension
por: Zhang, Jinbiao, et al.
Publicado: (2018)

Racial Differences in Insular Connectivity and Thickness and Related Cognitive Impairment in Hypertension
por: Chand, Ganesh B., et al.
Publicado: (2017)

Candesartan—the next anti-amyloid drug?
por: Yasar, Sevil
Publicado: (2022)

The Effect of Cerebral Small Vessel Disease on the Subtypes of Mild Cognitive Impairment
por: Li, Xudong, et al.
Publicado: (2021)

Profile of Cognitive Complaints in Vascular Mild Cognitive Impairment and Mild Cognitive Impairment
por: Gu, Jenny, et al.
Publicado: (2013)

The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition
por: Hajjar, Ihab, et al.
Publicado: (2009)

The mean diffusivity of forceps minor is useful to distinguish amnestic mild cognitive impairment from mild cognitive impairment caused by cerebral small vessel disease
por: Zhang, Yue, et al.
Publicado: (2022)

Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing
por: O’Neill, R. A., et al.
Publicado: (2021)

Dosimetry of patients submitted to cerebral PET/CT for the diagnosis of mild cognitive impairment
por: Santana, Priscila do Carmo, et al.
Publicado: (2014)

Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis
por: Tabatabaei-Jafari, Hossein, et al.
Publicado: (2015)

Altered Regional Cerebral Blood Perfusion in Mild Cognitive Impairment Patients with Dizziness
por: Na, Seunghee, et al.
Publicado: (2020)

Is cognitive impairment the fourth diabetic microvascular complication?
por: Kawamura, Takahiko, et al.
Publicado: (2011)

Candesartan cilexetil in the treatment of chronic heart failure
por: Baguet, Jean-Philippe, et al.
Publicado: (2009)

Cardio classics revisited – focus on the role of candesartan
por: De Rosa, Maria Leonarda
Publicado: (2010)

Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent Evaporation (†)
por: Vaculikova, Eliska, et al.
Publicado: (2012)

Adherence to Life’s Simple 7 and Cognitive Function Among Older Adults: The National Health and Nutrition Examination Survey 2011 to 2014
por: Wei, Jingkai, et al.
Publicado: (2022)

Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice
por: Ahmed, Heba A., et al.
Publicado: (2022)

Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review, Meta-Analysis, and Meta-Regression
por: Yeh, Tsai-Chu, et al.
Publicado: (2022)

Asymmetric Cerebral Blood Flow in Patients with Mild Cognitive Impairment: Possible Relationship to Further Cognitive Deterioration
por: Edman, Åke, et al.
Publicado: (2011)

Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors
por: Hajjar, Ihab, et al.
Publicado: (2022)

In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease
por: Low, Audrey, et al.
Publicado: (2021)

Dynamic cerebral autoregulation in Alzheimer’s disease and mild cognitive impairment: A systematic review
por: Heutz, Rachel, et al.
Publicado: (2023)

Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease
por: Oviedo, Diana C., et al.
Publicado: (2018)

Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study)
por: Mejia-Renteria, Hernan, et al.
Publicado: (2022)

Pharmacotherapy of mild cognitive impairment
por: Gauthier, Serge
Publicado: (2004)

Mild cognitive impairment: The dilemma
por: Pinto, Charles, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_opgaoi09o8lk4c8nr5roe5kun0